首页> 美国卫生研究院文献>Frontiers in Immunology >Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
【2h】

Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation

机译:调节性T细胞:移植中的免疫耐受性的承诺中的严重竞争者。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Regulatory T cells (Tregs) play an important role in immunoregulation and have been shown in animal models to promote transplantation tolerance and curb autoimmunity following their adoptive transfer. The safety and potential therapeutic efficacy of these cells has already been reported in Phase I trials of bone-marrow transplantation and type I diabetes, the success of which has motivated the broadened application of these cells in solid-organ transplantation. Despite major advances in the clinical translation of these cells, there are still key questions to be addressed to ensure that Tregs attest their reputation as ideal candidates for tolerance induction. In this review, we will discuss the unique traits of Tregs that have attracted such fame in the arena of tolerance induction. We will outline the protocols used for their ex vivo expansion and discuss the future directions of Treg cell therapy. In this regard, we will review the concept of Treg heterogeneity, the desire to isolate and expand a functionally superior Treg population and report on the effect of differing culture conditions. The relevance of Treg migratory capacity will also be discussed together with methods of in vivo visualization of the infused cells. Moreover, we will highlight key advances in the identification and expansion of antigen-specific Tregs and discuss their significance for cell therapy application. We will also summarize the clinical parameters that are of importance, alongside cell manufacture, from the choice of immunosuppression regimens to the number of injections in order to direct the success of future efficacy trials of Treg cell therapy. Years of research in the field of tolerance have seen an accumulation of knowledge and expertise in the field of Treg biology. This perpetual progression has been the driving force behind the many successes to date and has put us now within touching distance of our ultimate success, immunological tolerance.
机译:调节性T细胞(Tregs)在免疫调节中起重要作用,并已在动物模型中显示出在过继转移后可促进移植耐受性并抑制自身免疫。这些细胞的安全性和潜在的治疗功效已经在骨髓移植和I型糖尿病的I期试验中得到了报道,其成功推动了这些细胞在固体器官移植中的广泛应用。尽管这些细胞的临床翻译取得了重大进展,但仍然需要解决一些关键问题,以确保Treg证明其作为诱导耐受的理想候选者的声誉。在这篇综述中,我们将讨论在耐受性诱导领域引起人们广泛关注的Tregs的独特特征。我们将概述用于体外扩增的方案,并讨论Treg细胞疗法的未来方向。在这方面,我们将回顾Treg异质性的概念,分离和扩展功能优越的Treg群体的愿望,并报告不同培养条件的影响。 Treg迁移能力的相关性也将与注入细胞的体内可视化方法一起讨论。此外,我们将重点介绍抗原特异性Treg的鉴定和扩展方面的关键进展,并讨论其对细胞治疗应用的重要性。我们还将总结与细胞生产一样重要的临床参数,从免疫抑制方案的选择到注射次数,以指导Treg细胞疗法未来疗效试验的成功。在耐受性领域的多年研究中,已经看到了Treg生物学领域的知识和专业知识的积累。这种持续发展一直是迄今为止许多成功背后的推动力,并且使我们现在距我们的最终成功(免疫耐受)不远。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号